Infections from invasive () frequently occur in food and can cause high morbidity and death. Thus, the sensitive, specific, and rapid detection of is critical for ensuring food safety and public health. Herein, a fluorescence immunoassay for trace detection was designed based on guinea pig antibody-functionalized magnetic nanoparticles (FeO NPs/pAb1) and rabbit antibody-anchored CdZnTe quantum dots (CdZnTe QDs/pAb2). Because of the antibody-directed magnetic separation and long-wave fluorescent emission for CdZnTe QD indication, the constructed immunoassay strategy presented excellent anti-interference performance toward a biological matrix. The immunosensor exhibited a wide detection range of 1 to 10 CFU mL for and a low limit of detection (LOD) of 1 CFU mL, achieving an exceptionally sensitive detection of trace . Meanwhile, the immunosensor showed good specificity and had a short time-consumption of 60 min to realize the accurate determination of trace in spiked tap water and pasteurized milk samples.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/d1ay02106k | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
In-depth immunochemical characterization of the serum antibody response using a dual-titration microspot assay.
Front Immunol
March 2025
R&D Laboratory, Diagnosticum Zrt, Budapest, Hungary.
Antigen specific humoral immunity can be characterized by the analysis of serum antibodies. While serological assays for the measurement of specific antibody levels are available, these are not quantitative in the biochemical sense. Yet, understanding humoral immune responses quantitatively on the systemic level would need a universal, complete, quantitative, comparable measurement method of antigen specific serum antibodies of selected immunoglobulin classes.
View Article and Find Full Text PDFBackground: Tuberculosis is still a significant global health challenge, with latent tuberculosis infection (LTBI) posing a risk for the development of active disease. This study aimed to compare the performance of the STAN-DARD F TB-Feron FIA test with the QuantiFERON-TB Gold Plus, a test endorsed by the World Health Organization (WHO), in detecting LTBI.
Methods: We included 137 participants, out of which 58.
High-sensitivity BK virus detection system using viewRNA in situ hybridization.
Diagn Microbiol Infect Dis
March 2025
Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China. Electronic address:
Objective: To establish a reliable molecular diagnostic system for precise identification of BK virus (BKV)-associated pathologies.
Methods: We designed a set of in-situ hybridization (ISH) probes targeting two conserved sequences within the large T antigen region of BKV, exhibiting highly specificity from JC virus and SV40 homologs. By integrating the branched DNA signal amplification technology with these probes, we developed a novel ViewRNA-ISH detection system.
Efficacy and mechanism of inhibition of the GPR30-PI3K pathway by 4-phenylbutyric acid in the treatment of intrahepatic cholestasis of pregnancy.
J Mol Histol
March 2025
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, No. 1 of Youyi Road, Yuanjiagang, Daping Street, Yuzhong District, Chongqing, 400042, China.
Intrahepatic cholestasis of pregnancy (ICP) is a liver disease that manifests predominantly in the later stages of pregnancy. The primary treatment currently involves the use of ursodeoxycholic acid (UDCA). In this study, the therapeutic effectiveness of 4-phenylbutyric acid (4-PBA) in the treatment of ICP, as well as the potential mechanisms involved, are investigated to offer new references for clinical treatment decisions using ICP model.
View Article and Find Full Text PDFOrigami Paper-Based Immunoassay Device with CRISPR/Cas12a Signal Amplification.
ACS Sens
March 2025
Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan.
In clinical diagnosis, the determination of target proteins at low concentration levels is generally performed by immunoassays, such as the enzyme-linked immunosorbent assay (ELISA), which is a time-consuming process. To date, paper-based ELISA platforms enabling faster and less expensive analysis have been developed, but their important issue for clinical applications is the limited sensitivity compared to conventional ELISA. To address this challenge, this paper introduces a simple, rapid, and highly sensitive detection method for non-nucleic acid targets achieved by integrating the CRISPR/Cas12a system into paper-based ELISA.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!